Barinthus Biotherapeutics
Yahoo Finance • 4 hours ago
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers–CMA, HFWA, BRNS, and FITB
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story
Yahoo Finance • 11 days ago
Barinthus Biotherapeutics GAAP EPS of -$0.36 beats by $0.09
* Barinthus Biotherapeutics press release [https://seekingalpha.com/pr/20298721-barinthus-bio-reports-third-quarter-2025-financial-results-and-updates-on-corporate] (BRNS [https://seekingalpha.com/symbol/BRNS]): Q3 GAAP EPS of -$0.36 bea... Full story
Yahoo Finance • 12 days ago
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
Single ascending dose data readout for VTP-1000 expected before the end of 2025Enrollment advancing in multiple ascending dose part of the AVALON trial; data expected in the second half of 2026Proposed combination with Clywedog Therapeutic... Full story
Yahoo Finance • last month
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
BALA CYNWYD, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story
Yahoo Finance • last month
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders
NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • last month
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Barinthus Biotherapeutics plc (NASDAQ: BRNS)
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story
Yahoo Finance • last month
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECO, BRNS, VRNT on Behalf of Shareholders
NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • 2 months ago
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
GERMANTOWN, MD and ALTRINCHAM, UK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The combined company, Clywedog Therapeutics, will bring a portfolio that includes three differentiated, clinical stage product candidates which are being studied for... Full story
Yahoo Finance • 2 months ago
Barinthus Biotherapeutics to combine with Clywedog Therapeutics
* Barinthus Biotherapeutics (NASDAQ:BRNS [https://seekingalpha.com/symbol/BRNS]) and Clywedog Therapeutics said on Tuesday that they have entered into a definitive merger agreement [https://seekingalpha.com/pr/20248639-barinthus-biothera... Full story
Yahoo Finance • 8 months ago
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, potentially curative immunotherapy for celiac disease (VTP-1000) in the clinic, with first data exp... Full story
